Ronna Abramson
In a press release Friday, SCO said it was performing a valuation of the conversion feature associated with the issue, which will not affect revenue or cash. SCO reiterated its prior guidance for fourth-quarter revenue ranging from $22 million to $25 million. Although such delays can raise red flags, one buy-side source, who asked that his name not be used, said he believed the reason was legitimate. "I don't think there's any funny business going on," he said. The source, who holds SCO shares, suggested a "market effect" was also pushing the stock down, with investors taking profits in small-cap tech names that have enjoyed a strong run this year. SCO shares have soared in the past 12 months, trading as high as $22.29 in mid-October vs. a low under $1.50 a year ago, while drawing a whopping 21.6% short interest as of Nov. 10. But on some level, SCO has turned its stock into a lottery ticket on the outcome of its controversial suit against IBM. On Monday, investors were rethinking the worth of those tickets.
Apple and AT&T were among the most searched stocks on TheStreet.com Friday. Here's what Cramer had to say about them recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Looking for deep value with Defiance Asset Management, polling big investors about where the market's headed, plus much more.
See who made what calls.
3 Stocks I Saw On TVDan Fitzpatrick examines three stocks viewed on Fast Money and Mad Money Today's stocks include Deere & Co., Petrobras and MBIA
TheStreet.com Ratings checks in on First Community Bancorp and First Niagara Financial Group two months after recommending the stock.
Take-Two's latest hit receives a perfect score from industry reviewers.
- Cramer's 'Mad Money' Recap: Mad Money's Rally Playbook
- The Polycarbonate Price Cut
- CalPERS Pushes for Clean House at Standard Pacific
- Investing in China: What You Need to Know
- Coming Week: 'Glimmer of Hope'
- Top Stocks With Insider Buying, Buybacks
- New Solar ETF Helps Spread Sector's Risk
- Feuerstein's Biotech-Stock Mailbag
- Need to Own Energy? Here's How to Do It
- My Company Doesn't Provide Health Insurance (Gulp!)
Sponsored by:

BEAT THE STREET GAME:



